Literature DB >> 26750518

Q-learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia.

Ashkan Ertefaie1,2, Susan Shortreed3, Bibhas Chakraborty4,5.   

Abstract

Q-learning is a regression-based approach that uses longitudinal data to construct dynamic treatment regimes, which are sequences of decision rules that use patient information to inform future treatment decisions. An optimal dynamic treatment regime is composed of a sequence of decision rules that indicate how to optimally individualize treatment using the patients' baseline and time-varying characteristics to optimize the final outcome. Constructing optimal dynamic regimes using Q-learning depends heavily on the assumption that regression models at each decision point are correctly specified; yet model checking in the context of Q-learning has been largely overlooked in the current literature. In this article, we show that residual plots obtained from standard Q-learning models may fail to adequately check the quality of the model fit. We present a modified Q-learning procedure that accommodates residual analyses using standard tools. We present simulation studies showing the advantage of the proposed modification over standard Q-learning. We illustrate this new Q-learning approach using data collected from a sequential multiple assignment randomized trial of patients with schizophrenia.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Q-learning; Residual analysis; SMART designs; dynamic treatment regimes

Mesh:

Substances:

Year:  2016        PMID: 26750518      PMCID: PMC4853263          DOI: 10.1002/sim.6859

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

2.  A Generalization Error for Q-Learning.

Authors:  Susan A Murphy
Journal:  J Mach Learn Res       Date:  2005-07       Impact factor: 3.654

3.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

4.  Adaptive Confidence Intervals for the Test Error in Classification.

Authors:  Eric B Laber; Susan A Murphy
Journal:  J Am Stat Assoc       Date:  2011-09-01       Impact factor: 5.033

5.  Evaluating multiple treatment courses in clinical trials.

Authors:  P F Thall; R E Millikan; H G Sung
Journal:  Stat Med       Date:  2000-04-30       Impact factor: 2.373

Review 6.  A "SMART" design for building individualized treatment sequences.

Authors:  H Lei; I Nahum-Shani; K Lynch; D Oslin; S A Murphy
Journal:  Annu Rev Clin Psychol       Date:  2011-12-12       Impact factor: 18.561

7.  Q-LEARNING WITH CENSORED DATA.

Authors:  Yair Goldberg; Michael R Kosorok
Journal:  Ann Stat       Date:  2012-02-01       Impact factor: 4.028

8.  Estimation of optimal dynamic treatment regimes.

Authors:  Ying-Qi Zhao; Eric B Laber
Journal:  Clin Trials       Date:  2014-05-28       Impact factor: 2.486

9.  A multiple imputation strategy for sequential multiple assignment randomized trials.

Authors:  Susan M Shortreed; Eric Laber; T Scott Stroup; Joelle Pineau; Susan A Murphy
Journal:  Stat Med       Date:  2014-06-11       Impact factor: 2.373

10.  Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

Authors:  Marvin S Swartz; Diana O Perkins; T Scott Stroup; Joseph P McEvoy; Jennifer M Nieri; David C Haak
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  4 in total

1.  Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.

Authors:  William J Artman; Inbal Nahum-Shani; Tianshuang Wu; James R Mckay; Ashkan Ertefaie
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

2.  Noninferiority and equivalence tests in sequential, multiple assignment, randomized trials (SMARTs).

Authors:  Palash Ghosh; Inbal Nahum-Shani; Bonnie Spring; Bibhas Chakraborty
Journal:  Psychol Methods       Date:  2019-09-09

3.  Estimation and evaluation of linear individualized treatment rules to guarantee performance.

Authors:  Xin Qiu; Donglin Zeng; Yuanjia Wang
Journal:  Biometrics       Date:  2017-09-28       Impact factor: 2.571

4.  Optimal allocation to treatments in a sequential multiple assignment randomized trial.

Authors:  Andrea Morciano; Mirjam Moerbeek
Journal:  Stat Methods Med Res       Date:  2021-09-23       Impact factor: 3.021

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.